adverse selection

Suppose an insurer offers one flat price for health cover to everyone in town. Who lines up to buy? Disproportionately, the people who privately know they are likely to need it — the ones already feeling unwell, or expecting a big medical year. The healthy, who suspect they are a good risk, hang back because the price feels too high for them. So the buyers are sicker than average, claims run higher than the flat price assumed, the insurer must raise prices, the next-healthiest drop out, and the spiral repeats. That self-sorting is adverse selection.

Adverse selection is the tendency for those most likely to suffer a loss to be the keenest to buy insurance, and for low-risk people to opt out, when the insurer cannot tell them apart and charges them the same. It springs from asymmetric information: the customer knows more about their own risk than the insurer does. A simple feel: if the true average cost across everyone is 1,000 dollars but only the higher-risk half (true cost 1,500) actually buys at a 1,000 price, the insurer loses money, raises the price toward 1,500, and pushes out the next tier — the so-called 'death spiral.' Left unchecked, it can unravel a market entirely.

Fighting adverse selection is a core reason underwriting and risk classification exist. Insurers gather information (medical questions, exams, driving records), sort applicants into fairer price classes, use waiting periods and pre-existing-condition rules, and sometimes rely on mandates or group enrolment (like workplace health plans) so healthy people stay in the pool. The honest tension: the very tools that fight adverse selection can feel intrusive or unfair, and society sometimes bans certain rating factors (like genetic tests) on ethical grounds — accepting some adverse selection as the price of fairness.